ArticleBMJ open respiratory research2026
Lung function impairment at pulmonary TB and HIV/TB diagnosis: a South African cross-sectional cohort analysis.
Article in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo characterise the patterns and severity of impaired lung function at pulmonary tuberculosis (TB) diagnosis and assess the impact of HIV co-infection on TB-associated lung injury.
settingA cross-sectional analysis of adults with and without HIV who presented with newly diagnosed drug-susceptible pulmonary TB in Johannesburg, South Africa.
participantsA total of 258 adults who were newly diagnosed with drug-susceptible pulmonary TB underwent comprehensive pulmonary function tests (PFT). PRIMARY AND SECONDARY OUTCOME MEASURES: Five key PFT manoeuvres were evaluated: forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/FVC, total lung capacity (TLC) and haemoglobin-corrected diffusion capacity of the lungs for carbon monoxide (DLCO). Three primary outcomes were modelled: (1) normal versus abnormal lung function, defined as any key PFT manoeuvre z-score < lower limit of normal, (2) continuous z-scores for each PFT and (3) clinical patterns of lung function (normal, restriction, obstruction, mixed disorder and isolated low DLCO). Secondary outcomes included respiratory health-related quality-of-life measures assessed using the St. George's Respiratory Questionnaire (SGRQ).
resultsHIV/TB co-infection was associated with lower odds of any abnormal lung function (adjusted OR (aOR) 0.43, 95% CI 0.24 to 0.74) and lower odds of restrictive (aOR 0.46, 95% CI 0.24 to 0.87) and mixed patterns (aOR 0.22, 95% CI 0.07 to 0.66) compared with those with TB alone. HIV co-infection was also associated with better FEV1, FVC, FEV1/FVC and TLC z-scores. While those with HIV had less severe radiographic disease, respiratory symptoms were similar between groups (SGRQ total score: HIV-negative 22 (IQR: 13-38) vs HIV-positive 26 (IQR: 8-44), p>0.9).
conclusionsAdults with HIV/TB co-infection demonstrated a distinct clinical phenotype of TB-associated lung injury at TB diagnosis characterised by less severe radiographic and lung function impairment compared with those without HIV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.